United Therapeutics Corporation (NASDAQ:UTHR). Thompson Siegel & Walmsley LLC reports that it increased its …
INCY, STDY, and UTHR stocks are making notable moves on the charts today INCY is the top-performing S&P 500 Index (SPX) stock today, thanks to news the company is advancing its cancer drug program with Bristol-Myers Squibb Co …
United Therapeutics Corporation (UTHR - Free Report) reported adjusted earnings of $4.41 per share (including stock-based compensation benefit but excluding charges) for the second quarter of 2017, which were better than $4.39 per …
United Therapeutics Corporation (NASDAQ:UTHR) has been the object of insider selling activity recently. Richard …
United Therapeutics Co. (NASDAQ:UTHR) – Stock analysts at Jefferies Group increased their Q3 2017 EPS estimates for United Therapeutics in a research note issued to investors on Thursday. Jefferies Group analyst E. Yang now forecasts …
Palo Alto Investors LLC now owns 1,883,315 shares of the biotechnology company’s stock worth $254,963,000 after buying an additional 14,500 shares during the period. Get United Therapeutics Corporation alerts: United Therapeutics …
Current levels places United Therapeutics Corporation (NASDAQ:UTHR)'s stock about 1.40% from the 50-day high and 15.77% away from the 50-day low. Shares of United Therapeutics Corporation (NASDAQ:UTHR) opened at 127.57 on …
Shares of United Therapeutics Corporation (NASDAQ:UTHR) opened at 127.57 on Thursday. The stock rose 1.56% or $1.44 reaching $93.94 per share. United Therapeutics Corporation declared that its Board of Directors has initiated a …
Krensavage Asset Management Llc sold 4,855 shares as United Therapeutics Corp (UTHR)’s stock declined 27.66%. …